Protein Kinase C, antagonists & inhibitors
- Name
- Protein Kinase C, antagonists & inhibitors
- Accession Number
- DBCAT001440
- Description
Not Available
- Drugs
Drug Drug Description 7-Hydroxystaurosporine Not Available K-252a Not Available Debromohymenialdisine Not Available Aprinocarsen Investigated for use/treatment in lung cancer. Midostaurin An antineoplastic agent used to treat high-risk acute myeloid leukemia (AML) with specific mutations, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL). Ruboxistaurin Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus. Safingol Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific. Bisindolylmaleimide VIII Not Available Bisindolylmaleimide I Not Available Chelerythrine A benzophenanthridine alkaloid evaluated as a kinase-inhibitor. Go-6976 An inhibitor of calcium-dependent isoforms of protein kinase C.[A253002,A253007] - Drugs & Drug Targets